Brahm, C.G.; van Linde, M.E.; Enting, R.H.; Schuur, M.; Otten, R.H.J.; Heymans, M.W.; Verheul, H.M.W.; Walenkamp, A.M.E.
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review. Cancers 2020, 12, 586.
https://doi.org/10.3390/cancers12030586
AMA Style
Brahm CG, van Linde ME, Enting RH, Schuur M, Otten RHJ, Heymans MW, Verheul HMW, Walenkamp AME.
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review. Cancers. 2020; 12(3):586.
https://doi.org/10.3390/cancers12030586
Chicago/Turabian Style
Brahm, Cyrillo G., Myra E. van Linde, Roelien H. Enting, Maaike Schuur, René H.J. Otten, Martijn W. Heymans, Henk M.W. Verheul, and Annemiek M.E. Walenkamp.
2020. "The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review" Cancers 12, no. 3: 586.
https://doi.org/10.3390/cancers12030586
APA Style
Brahm, C. G., van Linde, M. E., Enting, R. H., Schuur, M., Otten, R. H. J., Heymans, M. W., Verheul, H. M. W., & Walenkamp, A. M. E.
(2020). The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review. Cancers, 12(3), 586.
https://doi.org/10.3390/cancers12030586